Celltrion Healthcare Co.

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

South Korea’s Doosan Group has entered the bidding war for SK Siltron Co., the world’s third-largest manufacturer of semiconductor wafer...

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

In an era of escalating geopolitical uncertainty, the head of one of the world’s largest private equity firms sees opportunity – not ret...

SK Inc., the holding company of SK Group, is in talks with Hahn & Co., a South Korean buyout firm, to sell SK Siltron Co., the country’s s...

Hahn & Co., South Korea’s largest private equity firm, has finalized the acquisition of SK Specialty Co., the world’s leading produc...

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Netmarble Corp., South Korea’s leading game developer, is slated to roll out “RF Online Next” on March 20, a revamp of the old tit...

CHA Biotech Co., South Korea’s leading stem cell therapeutics developer, plans to resume an initial public offering of CHA Healthcare Co., a m...

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

HMM Co., South Korea’s largest ocean carrier, is seeking to buy SK Shipping Co., excluding its liquefied natural gas (LNG) transportation busi...

EQT, the largest private equity firm in Europe, is setting its sights on healthcare, technology companies and business service providers in South Ko...

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

South Korean venture capital firm Partners Investment said on Thursday it will raise up to 215.5 billion won ($150 million) in a biotech fund jointl...

South Korea's Naver Webtoon said on Thursday its horror series Stagtown, popular in the US, will be made into a movie by Hollywood.Stagtown was di...

The global real estate market is poised for a recovery, led by industrial warehouses, residential facilities and data centers benefiting from declin...

LG CNS Co., a South Korean information technology service company, said on Monday it signed a memorandum of understanding (MOU) with Bear Robotics...

South Korea's automaker KG Mobility Corp. said on Thursday it partnered with the global car aftermarket solutions company Phinia to develop hydrogen...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Hyundai Motor Co. and its sibling Kia Corp. together shipped a record-high number of eco-friendly cars to overseas markets last year thanks to stron...

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Seoul-based private equity firm Hahn & Co. has agreed to buy the chemical mechanical polishing (CMP) pads manufacturing division of SK Enpulse C...

South Korea’s private equity firm Hahn & Co. is set to acquire a controlling stake in the world’s top specialty gas producer SK Spec...

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

South Korea's Celltrion Inc. said on Wednesday it received new drug submission (NDS) approval from the Food and Drug Administration (FDA) for Steq...

Celltrion Inc. on Tuesday launched its contract development and manufacturing organization unit Celltrion BioSolutions Co. in its foray into the CDM...

Celltrion Inc. is one step closer to commercializing its four new biosimilars in Europe after a committee of the European Medicines Agency (EMA) rec...